Analyze Diet

Topic:Influenza

Equine influenza is a highly contagious respiratory disease caused by influenza A viruses, specifically affecting horses. The disease is characterized by symptoms such as fever, coughing, nasal discharge, and lethargy. Transmission occurs primarily through aerosolized droplets and direct contact, leading to rapid spread among susceptible populations. Vaccination is a common preventive measure, though the virus's ability to mutate necessitates ongoing surveillance and vaccine updates. This page gathers peer-reviewed research studies and scholarly articles that explore the virology, epidemiology, clinical presentation, and management strategies of equine influenza, with a focus on its impact on equine health and welfare.
Boosting in equine influenza vaccination schedules: timing and time for a re-evaluation of requirements of national and international authorities.
Veterinary journal (London, England : 1997)    August 16, 2007   Volume 174, Issue 3 449-450 doi: 10.1016/j.tvjl.2007.06.012
Wood JL, Mumford JA, Mair TS, Slater J.No abstract available
Canine influenza virus: cross-species transmission from horses.
The Veterinary record    July 31, 2007   Volume 161, Issue 4 142-143 doi: 10.1136/vr.161.4.142-a
Newton R, Cooke A, Elton D, Bryant N, Rash A, Bowman S, Blunden T, Miller J, Hammond TA, Camm I, Day M.No abstract available
Equine influenza in England.
The Veterinary record    June 19, 2007   Volume 160, Issue 24 851 doi: 10.1136/vr.160.24.851
Newton R, Elton D, Bryant N, Rash A, Hammond TA.No abstract available
Is there a benefit from an early booster vaccination in the control of equine influenza?
Veterinary journal (London, England : 1997)    June 7, 2007   Volume 174, Issue 3 592-598 doi: 10.1016/j.tvjl.2007.03.004
Heldens JG, van Loon AA, van de Zande S.Conventional equine influenza vaccination schedules consist of a primary course of two vaccinations given 4-6 weeks apart followed by a third vaccination (booster) given approximately 5 months later. In between the primary course and the third vaccination, horses are generally considered not to be adequately protected against influenza. This study aimed to investigate whether Thoroughbred foals would benefit from a vaccination schedule in which the third vaccination was given earlier than in conventional vaccination schedules. The vaccines used were an inactivated whole virus equine influenza ...
Effective priming of foals born to immune dams against influenza by a canarypox-vectored recombinant influenza H3N8 vaccine.
Journal of comparative pathology    June 7, 2007   Volume 137 Suppl 1 S76-S80 doi: 10.1016/j.jcpa.2007.04.016
Minke JM, Toulemonde CE, Dinic S, Cozette V, Cullinane A, Audonnet JC.A classical limitation of early life immunization is the interference by maternally derived antibodies, which are known to inhibit the immune response to modified-live and killed vaccines. Several studies have convincingly shown that even minute amounts of maternally derived antibodies against equine influenza can strongly interfere with successful vaccination of foals born to immune mares. In this study we evaluated the response of foals born to vaccinated mares to immunization with a canarypox-vectored recombinant vaccine against equine influenza virus H3N8. The recombinant vaccine was able ...
Clinical pharmacokinetics of oseltamivir and its active metabolite oseltamivir carboxylate after oral administration in horses.
The Journal of veterinary medical science    April 6, 2007   Volume 69, Issue 3 293-296 doi: 10.1292/jvms.69.293
Yamanaka T, Yamada M, Tsujimura K, Kondo T, Nagata S, Hobo S, Kurosawa M, Matsumura T.The aim of this study was to investigate the pharmacokinetics of oseltamivir carboxylate (OC) in horses (n=6) after oral administration of its prodrug oseltamivir. The binding rate of OC to horse plasma proteins was negligible (<1%). Oral administration of oseltamivir of 2 mg/kg body weight of oseltamivir to horses provided a plasma concentration of OC (mean maximum concentration: 257.9 ng/ml) above the inhibitory concentrations against equine influenza A viruses determined in vitro. However, because OC is rapidly eliminated from horse plasma (mean elimination half-life: 2.5 hr), administratio...
Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.
American journal of veterinary research    February 3, 2007   Volume 68, Issue 2 213-219 doi: 10.2460/ajvr.68.2.213
Minke JM, Toulemonde CE, Coupier H, Guigal PM, Dinic S, Sindle T, Jessett D, Black L, Bublot M, Pardo MC, Audonnet JC.To determine onset and duration of immunity provided by a 2- or 3-dose series of a new canarypox-vectored recombinant vaccine for equine influenza virus (rCP-EIV vaccine) expressing the hemagglutinin genes of influenza H3N8 virus strains A/eq/Kentucky/94 and A/eq/Newmarket/2/93 in ponies. Methods: Forty-nine 1- to 3-year-old male Welsh Mountain Ponies that were seronegative for equine influenza virus. Methods: Vaccinated and control ponies were challenged with aerosolized influenza virus A/eq/Sussex/89 (H3N8), representative of the Eurasian lineage of circulating influenza viruses. In trial 1,...
An outbreak of equine influenza virus in vaccinated horses in Italy is due to an H3N8 strain closely related to recent North American representatives of the Florida sub-lineage.
Veterinary microbiology    November 25, 2006   Volume 121, Issue 1-2 56-63 doi: 10.1016/j.vetmic.2006.11.017
Martella V, Elia G, Decaro N, Di Trani L, Lorusso E, Campolo M, Desario C, Parisi A, Cavaliere N, Buonavoglia C.In December 2005, equine influenza virus infection was confirmed as the cause of clinical respiratory disease in vaccinated horses in Apulia, Italy. The infected horses had been vaccinated with a vaccine that contained strains representatives from both the European (A/eq/Suffolk/89) and American (A/eq/Newmarket/1/93) H3N8 influenza virus lineages, and the H7N7 strain A/eq/Praga/56. Genetic characterization of the hemagglutinin (HA) and neuraminidase (NA) genes of the virus from the outbreak, indicated that the isolate (A/eq/Bari/2005) was an H3N8 strain closely related to recent representative...
Efficacy of oseltamivir phosphate to horses inoculated with equine influenza A virus.
The Journal of veterinary medical science    October 5, 2006   Volume 68, Issue 9 923-928 doi: 10.1292/jvms.68.923
Yamanaka T, Tsujimura K, Kondo T, Hobo S, Matsumura T.We investigated the efficacy of the oral administration of oseltamivir phosphate (OP) in horses experimentally infected with equine influenza A virus (H3N8). Nine horses were divided into three horses each of control, treatment and prophylaxis groups. An administration protocol for the treatment group (2 mg/kg of body weight, twice a day for five days) was started immediately after the onset of pyrexia (above 38.9 degrees C). An administration protocol for the prophylaxis group (2 mg/kg of body weight, once a day for five days) was started on a day before viral inoculation. In the treatment gr...
Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine.
Veterinary immunology and immunopathology    September 6, 2006   Volume 114, Issue 1-2 103-110 doi: 10.1016/j.vetimm.2006.07.013
Lopez AM, Hecker R, Mutwiri G, van Drunen Littel-van den Hurk S, Babiuk LA, Townsend HG.Previous studies have shown that protection against equine influenza virus (EIV) is partially mediated by virus-specific IgGa and IgGb. In this study we tested whether addition of a CpG ODN formulation to a commercial killed virus vaccine would enhance EIV-specific IgGa and IgGb antibody responses, and improve protection against an experimental EIV challenge. Thirty naïve horses were assigned to one of three groups and vaccinated as follows: 10 were given vaccine (Encevac TC4, Intervet Inc.) alone, 10 were given vaccine plus 0.25 mg CpG ODN 2007 formulated with 30% Emulsigen (CpG/Em), and 10 ...
Inability of kaolin treatment to remove nonspecific inhibitors from equine serum for the hemagglutination inhibition test against equine H7N7 influenza virus. Boliar S, Stanislawek W, Chambers TM.The hemagglutination inhibition test is used by many diagnostic and surveillance laboratories for detection of antibodies to influenza viruses. It is well known that the hemagglutination inhibition test is affected by nonspecific inhibitors present in equine serum. Several serum treatments are in use to remove these inhibitors, including treatment with kaolin. Discrepant results were observed in the authors' laboratories when using kaolin treatment before testing equine sera for antibodies against equine influenza virus (EIV) subtype-1 (H7N7). It is demonstrated here that kaolin treatment lead...
In vitro efficacies of oseltamivir carboxylate and zanamivir against equine influenza A viruses.
The Journal of veterinary medical science    May 9, 2006   Volume 68, Issue 4 405-408 doi: 10.1292/jvms.68.405
Yamanaka T, Tsujimura K, Kondo T, Matsumura T.To investigate the possibilities of two NA inhibitors [oseltamivir carboxylate (OC) and zanamivir (ZA)] as the clinical agents for equine influenza A virus (EIV) infection, we examined the efficacies of these inhibitors against twelve EIVs in vitro. OC and ZA inhibited NA activities of all EIVs with 50% inhibitory concentrations with ranging from 0.017 to 0.130 and from 0.010 to 0.074 microM, respectively. OC and ZA inhibited plaque-forming of all EIVs in MDCK cells with 50% effective concentrations with ranging from 0.015 to 0.097 and from 0.016 to 0.089 microM, respectively, except for one s...
Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus.
Veterinary immunology and immunopathology    April 18, 2006   Volume 112, Issue 3-4 225-233 doi: 10.1016/j.vetimm.2006.02.007
Paillot R, Kydd JH, Sindle T, Hannant D, Edlund Toulemonde C, Audonnet JC, Minke JM, Daly JM.In horses, equine influenza virus (EIV) is a leading cause of respiratory disease. Conventional inactivated vaccines induce a short-lived immune response. By comparison, natural infection confers a long-term immunity to re-infection. An aim of new equine influenza vaccines is to more closely mimic natural infection in order to achieve a better quality of immunity. A new live recombinant vaccine derived from the canarypox virus vector and expressing haemagglutinin genes of EIV (subtype H3N8) has been developed. Stimulation of the immune system was studied after immunisation with this canarypox-...
Investigation of equine influenza cases exhibiting neurological disease: coincidence or association?
Journal of comparative pathology    March 9, 2006   Volume 134, Issue 2-3 231-235 doi: 10.1016/j.jcpa.2005.09.001
Daly JM, Whitwell KE, Miller J, Dowd G, Cardwell JM, Smith KC.Equine influenza is usually a transient and self-limiting disease. However, during an outbreak of equine influenza in the UK in 2003 there were reports of unusually severe clinical signs among unvaccinated animals. Two influenza-infected horses developed neurological signs, and one was subjected to euthanasia. Post-mortem examination of the brain revealed viral-type non-suppurative encephalitis, and influenza virus antigen was demonstrated by immunolabelling of sections of nasal mucosa. A syndrome known as influenza-associated encephalopathy has been described in man. Although not proved, the ...
Vaccination against equine influenza: quid novi?
Vaccine    February 28, 2006   Volume 24, Issue 19 4047-4061 doi: 10.1016/j.vaccine.2006.02.030
Paillot R, Hannant D, Kydd JH, Daly JM.Equine influenza virus is a leading cause of respiratory disease in the horse. Equine influenza vaccines containing inactivated virus were first developed in the 1960s. Despite their intensive use, equine influenza outbreaks still continue to occur and therefore new strategies of vaccination are necessary to improve vaccine efficacy. Numerous methods of vaccination have been evaluated and commercialised in the horse, the most recent being the cold-adapted influenza virus and poxvirus-based vaccines. As a large animal model, the horse is also a useful species in which to evaluate the potential ...
Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
Veterinary immunology and immunopathology    February 14, 2006   Volume 111, Issue 1-2 67-80 doi: 10.1016/j.vetimm.2006.01.010
Holmes MA, Townsend HG, Kohler AK, Hussey S, Breathnach C, Barnett C, Holland R, Lunn DP.Horses are commonly vaccinated to protect against pathogens which are responsible for diseases which are endemic within the general horse population, such as equine influenza virus (EIV) and equine herpesvirus-1 (EHV-1), and against a variety of diseases which are less common but which lead to greater morbidity and mortality, such as eastern equine encephalomyelitis virus (EEE) and tetanus. This study consisted of two trials which investigated the antigenicity of commercially available vaccines licensed in the USA to protect against EIV, EHV-1 respiratory disease, EHV-1 abortion, EEE and tetan...
Description of the outbreak of equine influenza (H3N8) in the United Kingdom in 2003, during which recently vaccinated horses in Newmarket developed respiratory disease.
The Veterinary record    February 14, 2006   Volume 158, Issue 6 185-192 doi: 10.1136/vr.158.6.185
Newton JR, Daly JM, Spencer L, Mumford JA.Between March and May 2003, equine influenza virus infection was confirmed as the cause of clinical respiratory disease among both vaccinated and unvaccinated horses of different breeds and types in at least 12 locations in the UK. In the largest outbreak, 21 thoroughbred training yards in Newmarket, with more than 1300 racehorses, were affected, with the horses showing signs of coughing and nasal discharge during a period of nine weeks. Many of the infected horses had been vaccinated during the previous three months with a vaccine that contained representatives from both the European (A/eq/Ne...
Equine influenza in dogs: too late to bolt the stable door?
Veterinary journal (London, England : 1997)    December 28, 2005   Volume 171, Issue 1 7-8 doi: 10.1016/j.tvjl.2005.09.014
Daly JM.No abstract available
Co-infection between influenza virus and flagellated bacteria.
Revista do Instituto de Medicina Tropical de Sao Paulo    November 16, 2005   Volume 47, Issue 5 275-280 doi: 10.1590/s0036-46652005000500007
Mancini DA, Mendonça RM, Dias AL, Mendonça RZ, Pinto JR.Trypsin is required in the hemagglutinin (HA) cleavage to in vitro influenza viruses activation. This HA cleavage is necessary for virus cell entry by receptor-mediated endocytosis. Bacteria in the respiratory tract are potential sources of proteases that could contribute to the cleavage of influenza virus in vivo. From 47 samples collected from horses, pigs, and from humans, influenza presence was confirmed in 13 and these samples demonstrated co-infection of influenza with flagellated bacteria, Stenotrophomonas maltophilia from the beginning of the experiments. Despite treatment with antibio...
Real-time reverse transcription PCR for detection and quantitative analysis of equine influenza virus.
Journal of clinical microbiology    October 7, 2005   Volume 43, Issue 10 5055-5057 doi: 10.1128/JCM.43.10.5055-5057.2005
Quinlivan M, Dempsey E, Ryan F, Arkins S, Cullinane A.Equine influenza is a cause of epizootic respiratory disease of the equine. The detection of equine influenza virus using real-time Light Cycler reverse transcription (RT)-PCR technology was evaluated over two influenza seasons with the analysis of 171 samples submitted for viral respiratory disease. Increased sensitivity was found in overall viral detection with this system compared to Directigen Flu A and virus isolation, which were 40% and 23%, respectively, that of the RT-PCR. The assay was also evaluated as a viable replacement for the more traditional methods of quantifying equine influe...
The use of a systemic prime/mucosal boost strategy with an equine influenza ISCOM vaccine to induce protective immunity in horses.
Veterinary immunology and immunopathology    August 10, 2005   Volume 108, Issue 3-4 345-355 doi: 10.1016/j.vetimm.2005.06.009
Crouch CF, Daly J, Henley W, Hannant D, Wilkins J, Francis MJ.In horses, natural infection confers long lasting protective immunity characterised by mucosal IgA and humoral IgGa and IgGb responses. In order to investigate the potential of locally administered vaccine to induce a protective IgA response, responses generated by vaccination with an immunostimulating complex (ISCOM)-based vaccine for equine influenza (EQUIP F) containing A/eq/Newmarket/77 (H7N7), A/eq/Borlänge/91 (H3N8) and A/eq/Kentucky/98 (H3N8) using a systemic prime/mucosal boost strategy were studied. Seven ponies in the vaccine group received EQUIP F vaccine intranasally 6 weeks after...
Viruses associated with outbreaks of equine respiratory disease in New Zealand.
New Zealand veterinary journal    July 21, 2005   Volume 50, Issue 4 132-139 doi: 10.1080/00480169.2002.36299
Dunowska M, Wilks CR, Studdert MJ, Meers J.To identify viruses associated with respiratory disease in young horses in New Zealand. Methods: Nasal swabs and blood samples were collected from 45 foals or horses from five separate outbreaks of respiratory disease that occurred in New Zealand in 1996, and from 37 yearlings at the time of the annual yearling sales in January that same year. Virus isolation from nasal swabs and peripheral blood leukocytes (PBL) was undertaken and serum samples were tested for antibodies against equine herpesviruses (EHV-1, EHV-2, EHV-4 and EHV-5), equine rhinitis-A virus (ERAV), equine rhinitis-B virus (ERBV...
Attenuation of equine influenza viruses through truncations of the NS1 protein.
Journal of virology    June 16, 2005   Volume 79, Issue 13 8431-8439 doi: 10.1128/JVI.79.13.8431-8439.2005
Quinlivan M, Zamarin D, García-Sastre A, Cullinane A, Chambers T, Palese P.Equine influenza is a common disease of the horse, causing significant morbidity worldwide. Here we describe the establishment of a plasmid-based reverse genetics system for equine influenza virus. Utilizing this system, we generated three mutant viruses encoding carboxy-terminally truncated NS1 proteins. We have previously shown that a recombinant human influenza virus lacking the NS1 gene (delNS1) could only replicate in interferon (IFN)-incompetent systems, suggesting that the NS1 protein is responsible for IFN antagonist activity. Contrary to previous findings with human influenza virus, w...
An epizootic of equine influenza in Upper Egypt in 2000.
Revue scientifique et technique (International Office of Epizootics)    May 3, 2005   Volume 23, Issue 3 921-930 doi: 10.20506/rst.23.3.1539
Abd El-Rahim IH, Hussein M.This study describes an epizootic of respiratory tract disease caused by influenza virus infection in a large population of equines in Luxor and Aswan, Upper Egypt, during the winter of 2000. The epizootic started in January and the infection rate reached its peak in February before gradually decreasing until the end of April, 2000. Horses, donkeys and mules of all ages and both sexes were affected. Free movement of the infected equines and direct contact between the animals at markets facilitated the rapid spread of the disease. The cause of the epizootic was established by use of serological...
Efficacy of a recombinant equine influenza vaccine against challenge with an American lineage H3N8 influenza virus responsible for the 2003 outbreak in the United Kingdom.
The Veterinary record    April 9, 2005   Volume 156, Issue 12 367-371 doi: 10.1136/vr.156.12.367
Edlund Toulemonde C, Daly J, Sindle T, Guigal PM, Audonnet JC, Minke JM.Fifteen influenza-naive Welsh mountain ponies were randomly assigned to three groups of five. A single dose of a recombinant ALVAC vaccine was administered intramuscularly to five of the ponies, two doses, administered five weeks apart, were administered to five, and the other five served as unvaccinated, challenge controls. Two weeks after the completion of the vaccination programme, the ponies were all challenged by exposure to an aerosol of influenza virus A/eq/Newmarket/5/03. Their clinical signs were scored daily for 14 days according to a standardised scoring protocol, and nasal swabs we...
Characterisation of three equine influenza A H3N8 viruses from Germany (2000 and 2002): evidence for frozen evolution.
Veterinary microbiology    March 30, 2005   Volume 107, Issue 1-2 13-21 doi: 10.1016/j.vetmic.2005.01.010
Borchers K, Daly J, Stiens G, Kreling K, Kreling I, Ludwig H.Reported here are the results of antigenic and genetic characterisation of equine influenza strains causing local outbreaks reported to the Equine Diagnostic Centre in Berlin, Germany. In 2000, equine influenza virus was detected in a nasal swab from a non-vaccinated horse using a rapid diagnostic kit, but was not successfully isolated. Partial direct sequencing of the haemagglutinin (HA1) gene, indicated that the virus was a European lineage H3N8 subtype strain representative of strains isolated in several European countries during 2000. In 2002, two equine influenza viruses were isolated fro...
Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an ‘American lineage’ H3N8 virus.
Vaccine    November 9, 2004   Volume 23, Issue 3 418-425 doi: 10.1016/j.vaccine.2004.01.074
Crouch CF, Daly J, Hannant D, Wilkins J, Francis MJ.Protective responses generated by vaccination with an immuno-stimulating complex (ISCOM)-based vaccine for equine influenza (EQUIP F), containing a new 'American lineage' H3N8 virus, were studied. Seven ponies in the vaccine group received two intramuscular injections of EQUIP F given 6 weeks apart. Aerosol challenge with an A/eq/Newmarket/1/93 reference strain 4 weeks after booster vaccination resulted in clinical signs of infection and viral shedding in 7 influenza-naive control animals whereas the vaccinated ponies were significantly protected from both clinical signs and virus excretion. I...
Pulmonary ultrasonographic abnormalities associated with naturally occurring equine influenza virus infection in standardbred racehorses.
Journal of veterinary internal medicine    November 2, 2004   Volume 18, Issue 5 718-727 doi: 10.1892/0891-6640(2004)18<718:puaawn>2.0.co;2
Gross DK, Morley PS, Hinchcliff KW, Reichle JK, Slemons RD.The purpose of this investigation was to determine if naturally occurring acute infectious upper respiratory disease (IRD) caused by equine influenza virus is associated with ultrasonographically detectable pleural and pulmonary abnormalities in horses. Standardbred racehorses were evaluated for signs of IRD, defined as acute coughing or mucopurulent nasal discharge. For every horse with IRD (n = 16), 1 or 2 horses with no signs of IRD and the same owner or trainer (n = 30) were included. Thoracic ultrasonography was performed within 5-10 days of the onset of clinical disease in horses with IR...
Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines.
Vaccine    September 15, 2004   Volume 22, Issue 29-30 4101-4109 doi: 10.1016/j.vaccine.2004.02.048
Daly JM, Yates PJ, Newton JR, Park A, Henley W, Wood JL, Davis-Poynter N, Mumford JA.Two lineages of antigenically distinct equine influenza A H3N8 subtype viruses, American and European, co-circulate. Experiments were conducted in ponies to investigate the protection induced by vaccines containing virus from one lineage against challenge infection with homologous or heterologous virus. Regression analysis showed that vaccinated ponies with average pre-challenge single radial haemolysis (SRH) antibody levels (i.e. 45-190mm2) had a higher probability of becoming infected if they were vaccinated with virus heterologous to the challenge strain than if they were vaccinated with ho...
The effects of strain heterology on the epidemiology of equine influenza in a vaccinated population.
Proceedings. Biological sciences    August 13, 2004   Volume 271, Issue 1548 1547-1555 doi: 10.1098/rspb.2004.2766
Park AW, Wood JL, Daly JM, Newton JR, Glass K, Henley W, Mumford JA, Grenfell BT.We assess the effects of strain heterology (strains that are immunologically similar but not identical) on equine influenza in a vaccinated population. Using data relating to individual animals, for both homologous and heterologous vaccinees, we estimate distributions for the latent and infectious periods, quantify the risk of becoming infected in terms of the quantity of cross-reactive antibodies to a key surface protein of the virus (haemagglutinin) and estimate the probability of excreting virus (i.e. becoming infectious) given that infection has occurred. The data suggest that the infectio...
1 13 14 15 16 17 27